SOSV is a global venture capital firm that supports early-stage startups through active, founder-first development programs. Its flagship initiatives HAX and IndieBio provide facilities, engineering resources, services, and laboratory equipment to accelerate product development and prepare companies for subsequent funding rounds. SOSV focuses on deep technology across health, environmental, and cross-border software sectors, aiming to solve human and planetary health challenges. In addition to providing capital, the firm emphasizes intensive programmatic support to help portfolio companies move quickly from seed toward growth, including customer acquisition and scale. The firm operates globally with a bias toward startups targeting rapid international expansion, especially in Asia, and tends to back a small cohort of high-potential companies to accelerate their progress and attract leading investors.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.

Founded in 2000, General Catalyst is a venture capital firm specializing in early-stage and growth equity investments. It focuses on accelerating ideas, careers, and companies towards success by providing ongoing momentum and mentorship based on deep experience.

Founded in Singapore in 2017, Antler is an early-stage venture capital firm that invests globally. It focuses on backing exceptional founders from day one, offering a global community network of co-founders, talent, advisors, expansion support, and capital across various sectors such as technology, healthcare, finance, consumer goods, and more.

Right Side Capital Management is a San Francisco based venture capital firm that backs early-stage technology startups with a focus on pre-seed rounds. It makes about 75-100 investments per year in capital-efficient companies seeking to reach product-market fit, typically in rounds of 50k to 500k and pre-money valuations of 1M to 3M. The firm pursues opportunities outside the San Francisco Bay Area and New York City, and it invests across the United States, Canada, Israel, Australia, New Zealand, and Western Europe, with a portfolio spanning many states and roughly two hundred prior investments since its early operations.

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across multiple stages, from seed to late-stage. It pursues transformative technologies and follows a founder-friendly investment approach that provides substantial support with minimal interference. The firm invests in ventures solving difficult problems across sectors such as aerospace and transportation, artificial intelligence, advanced computing, energy, healthcare, biotechnology, cybersecurity, fintech, consumer internet, software, robotics, and related technology fields. It has backed notable companies early, including SpaceX, Palantir, and Facebook, reflecting a history of partnering with ambitious founders to scale breakthrough technologies.

SFC Capital is a United Kingdom based venture capital firm founded in 2012 that focuses on early-stage investments, including pre-seed and seed rounds, in sectors such as software, technology, e-commerce, consumer products, enterprise solutions, green technology, medical technology, and hospitality. It backs UK startups through an Angel Network and seed funds, providing capital and guidance and offering access to SEIS- and EIS-qualifying investment opportunities. The firm is described as a leading seed investor in the UK.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a technology-focused capital provider based in Philadelphia, founded in 1982 to advance the region's technology community. The organization funds and supports technology companies across Pennsylvania, especially in information technology, health, and physical sciences, investing substantial capital in early-stage and established ventures. It has invested over 170 million dollars in more than 1,750 regional technology companies and has launched university-industry partnerships to translate scientific discoveries into commercial products, while seeding regional initiatives that strengthen the entrepreneurial ecosystem and create jobs.

Sequoia Capital Israel is a venture capital firm that backs startups and growth companies across seed to late-stage rounds, with a focus on Israel. It invests across sectors including fintech, financial services, internet, mobile, technology, and healthcare, spanning banking, payments, advertising, ecommerce, data, security, software, and related enabling tech. Typical commitments range from 100,000 to 1 million in seed, 1 to 10 million in early venture, and 10 to 100 million in growth rounds. The firm is based in Tel Aviv and operates as part of Sequoia Capital's global network.

Andreessen Horowitz is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz and based in Menlo Park, California. It funds startups across the entire lifecycle, from seed to growth, with a broad focus on software and technology-enabled businesses. The firm backs companies in software, cloud infrastructure, digital platforms, data storage, and mobile and Internet services, as well as sectors at the intersection of technology with life sciences, such as bio healthcare and computational medicine. Its investments span artificial intelligence, fintech, consumer and enterprise software, crypto and blockchain, cybersecurity, and related infrastructure. Through strategic guidance and a hands-on approach, the firm aims to help portfolio companies scale and innovate.

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.

Founded in 2011, StartUp Health is dedicated to improving global health through collaboration with entrepreneurs. It invests in 'Health Transformers' across six continents, focusing on various health moonshots such as Access to Care, Cure Disease, and Mental Health. With over 330 companies in its portfolio, it's backed by prominent investors.

Established in 1999, Innovation Works is a prominent investor in Southwestern Pennsylvania's technology sector. It provides capital and resources to early-stage companies with high growth potential and significant regional impact, particularly focusing on robotics, AI, medical devices, retail technologies, and enterprise software.

Deerfield Management is a New York-based investment firm established in 1994 that focuses on healthcare. It operates across investment, information, and philanthropy to support the healthcare ecosystem. The firm provides private and public investments and offers long-term, structured capital to both public and private healthcare companies. Its portfolio spans life sciences, medical devices, diagnostics, digital health, and health services. As an investment adviser, it seeks opportunities in healthcare products and services and aims to accelerate innovation by combining capital with industry insight.

Founded in 1989, OrbiMed is a New York-based healthcare-dedicated investment firm managing approximately $5 billion in assets. It invests across the spectrum of healthcare companies, from private start-ups to large multinational corporations, focusing on biopharmaceuticals, life sciences, digital health, medical devices, and diagnostics sectors globally.

IP Group is a London-based corporate firm that provides financial, strategic, and commercial expertise to clients internationally. Founded in 2001, the company focuses on creating value through the commercialisation of intellectual property derived from research-intensive institutions. It manages the end-to-end process of identifying viable IP, developing or partnering to build value, and establishing commercial arrangements that translate scientific advances into practical products and businesses. IP Group combines industry insight and financial experience to support science- and technology-based ventures, offering capital as well as strategic guidance to help companies grow and accelerate the impact of research. Its work spans clean technology, life sciences, and other deep technology sectors, with a track record of backing and developing ventures that aim to deliver tangible societal and economic outcomes.

Founded in Boston in 2004, RA Capital is an investment firm specializing in life sciences and drug development. Its team, with backgrounds in biology, chemistry, medicine, and industry experience, invests in early-stage companies with promising technologies and products across healthcare and life science sectors.

Founded in 2014, Gaingels is a venture investment syndicate dedicated to supporting the LGBT+ community. It invests globally in companies led by LGBT+ founders or C-suite executives at all stages of growth, focusing on inclusivity and positive social change.

Northpond Ventures is a science-driven venture capital firm based in Bethesda, Maryland, with additional offices in San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, the firm concentrates its investments in life sciences, diagnostics, therapeutics, digital health, and related technologies, including AI and machine learning applications in biotech and medical fields, as well as environmental and other emerging technologies. It seeks to back early- and growth-stage companies that advance biomedical research, diagnostics, medical devices, and technology-enabled health solutions. The firm operates as a registered investment adviser and emphasizes building a better tomorrow through science-driven investing. It focuses on strategy, value creation, and supporting companies at the intersection of life sciences and technology, aiming to accelerate innovations that improve health outcomes.

Eli Lilly and Company is a global pharmaceutical leader engaged in the discovery, development, manufacture, and sale of medicines. It operates facilities in the United States, Puerto Rico, and many other countries, with products sold in about 135 countries. The company focuses on therapies in neuroscience, cardiometabolic, cancer, and immunology, and also conducts research in animal health and animal agriculture. Lilly supports patient outcomes and education through a philanthropic foundation that funds programs in underserved communities, including STEM education in Indianapolis.

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011, that manages investment portfolios and provides asset management services to clients across sectors, with a focus on software as a service companies, and analyzes market trends to inform its investment decisions while operating in finance, technology, and real estate.

Founded in 1986, ARCH Venture Partners is a venture capital firm specializing in investments that bring innovations in life sciences to market. It focuses on companies co-founded by scientists and entrepreneurs, with a strong track record in commercializing technologies from academic research institutions and national laboratories.

F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, affiliated with Fidelity Investments. It backs technology and life sciences entrepreneurs across the Americas, Europe, and Asia, drawing on Fidelity’s experience in funding early-stage companies. The firm focuses on sectors such as healthcare IT, medtech, therapeutics, fintech, frontier technologies, crypto, and broader information technology and technology-enabled services. With a global network of regional teams and affiliated funds, F-Prime provides domain expertise, strategic guidance, and industry connections to help founders build durable companies. It operates with a long-term, founder-centric approach, emphasizing value creation rather than external fundraising pressures.

Sequoia Capital is a venture capital firm based in Menlo Park, California, and a prominent global investor in seed, early and growth-stage startups. The firm backs companies across sectors including information technology, healthcare, financial services, energy, internet, mobile and enterprise software, often aiming to be a first investor and partner in fast-growing, proven teams. It pursues opportunities domestically in the United States and internationally in markets such as India, China and Israel, funding rounds spanning seed to growth with flexible investment sizes. Sequoia supports ambitious founders to push boundaries and build enduring companies.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

Founded in Tokyo in 1998, Global Brain is a venture capital firm focusing on seed to late-stage investments across various sectors globally. They have invested in over 300 startups, facilitating 25 IPOs and 61 M&As through hands-on support services.

Legend Capital is a Beijing-based venture capital firm and subsidiary of Legend Holdings. Founded in 2001, it focuses on early-stage and growth investments in technology-driven sectors with operations anchored in China and related markets. The firm backs companies in IT, internet applications and services, outsourcing, IC design and key components, as well as sectors such as telecommunications, media, healthcare, consumer and intelligent manufacturing. It manages multiple funds and actively supports portfolio companies with business development, market positioning and access to Chinese markets to create value. Legend Capital aims to back high-growth ventures and build lasting value in China's venture capital ecosystem.

Founded in 1986, Morningside Group is a venture capital firm based in the greater Boston area. It invests in companies with innovative science and technology across life sciences, digital health, AI, materials, and technology sectors.

Korea Investment Partners is a Seoul-based venture capital and private equity firm with more than three decades of investing experience. It operates globally from its Seoul headquarters with offices in Shanghai, Beijing and Sunnyvale, and manages multiple funds that invest across a broad spectrum of sectors including business-to-business services, media, healthcare, information technology, manufacturing, life sciences, oncology, mobile and gaming, augmented reality, industrials, real estate technology, mortgage technology, advertising technology, advanced manufacturing, the Internet of Things and mobility technologies. The firm has backed notable companies such as Kakao, Naver, YG Entertainment, Osstem Implant, Bodyfriend and Didi Chuxing, reflecting its emphasis on innovative entrepreneurs and large-scale opportunities.

Nina Capital is an international venture capital firm focused on healthcare transformation powered by information technology. It concentrates on pre-seed and seed-stage investments and is guided by deep industry experience and need-driven founders. The firm supports health tech solutions that aim to deliver lasting improvements in healthcare delivery and outcomes. Its diverse, multinational, and multidisciplinary team is led by former healthcare technology founders and operators, bringing together expertise from multiple healthcare and technology sectors. Founded in 2019 and based in Barcelona, Spain, Nina Capital has invested in companies across nearly 20 countries and has contributed to healthcare technology innovations that have touched the lives of more than 10 million people.

Matrix is a San Francisco based venture capital firm founded in 1977 that backs early-stage companies across AI, B2B, consumer, fintech, health tech, and infrastructure. It works with product teams from idea through Series A, offering hands-on support and strategic guidance to help portfolio companies reach scale. The team comprises former founders and operators who bring practical insight to building startups. Matrix operates globally, including Matrix Partners China, which builds long-term relationships with entrepreneurs in China and abroad and invests across sectors and stages. Over its history, Matrix has backed companies that progressed to IPOs or acquisitions, reflecting a focus on durable growth and long-term value creation through close founder collaboration and a global network.

Founded in 2012, Joyance Partners is a venture capital firm based in San Francisco. It invests in early-stage companies focused on emerging science and bio-based technologies that empower individuals' health and well-being within two years, as well as startups whose products increase joy, fulfillment, and independence for customers.

Founded in 2014, eHealth Ventures is a venture capital firm based in Tel Aviv, Israel. It focuses on investing in early-stage digital health companies, particularly those specializing in digital therapeutics and diagnostics.

Kurma Partners is a Paris-based investment firm founded in 2009 that concentrates on financing innovation in healthcare and biotechnology across Europe. It targets early-stage and development capital for companies in life sciences, biotechnology, digital health, and related fields, and emphasizes collaborations with research institutes and hospitals to advance therapies and medical technologies from concept to clinical development. The firm operates as a specialist investor in Europe, supporting ventures that bridge scientific discovery and patient impact through equity investments and strategic guidance.

8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies and create long-term value. Its activities span sectors such as healthcare, logistics, software, energy, manufacturing, enterprise IT, and life sciences, with a focus on supporting early-stage and growth opportunities in the United States and beyond.

Founded in 1863, Mayo Clinic is a non-profit organization based in Minnesota, United States. It provides comprehensive medical care services across various specialties, conducts extensive research, and offers education in clinical medicine.

Founded by Stephen Hays, a West Point graduate and former investment banker in aerospace & defense, What If Ventures invests in disruptive healthcare and defense industrial startups. With nearly $100 million deployed across over 80 companies since 2019, the firm focuses on these sectors due to their large addressable markets, complex regulations, significant government customers, and lack of successful innovation by new entrants.

Polaris Partners is a venture capital firm based in Boston, Massachusetts, with offices in San Francisco. Founded in 1996, it targets investments in technology and life science companies across the United States and Europe, supporting startups from early formation to profitable growth. The firm's healthcare and biotechnology focus encompasses digital health, consumer-centric care delivery, patient-provider solutions, data science and analytics, as well as therapeutics, genomics and other life science platforms. It backs companies across business-to-business and business-to-consumer models, software as a service, healthcare information technology and health tech sectors, partnering with repeat entrepreneurs to build durable, scale-ready businesses.

Accel is a venture capital firm founded in 1983 in Palo Alto, California, that backs early and growth-stage technology startups worldwide. It concentrates on software, cloud, data, mobile, digital media, and adjacent sectors, including consumer and enterprise technology, fintech, security, and healthcare. The firm supports entrepreneurs with long-term guidance and the resources needed to build world-class, category-defining companies. Accel maintains offices in Palo Alto, San Francisco, London, and Bangalore, and has backed a broad portfolio featuring notable companies such as Atlassian, Facebook, Dropbox, Slack, Spotify, and Cloudera.

Founded in 2015, FJ Labs is a New York-based venture capital firm focusing on stage-agnostic investments in marketplaces and consumer-facing startups. Their investment range varies from $50,000 to $5,000,000, typically at seed or series A stages.

Pear is an early-stage venture capital firm founded in 2013 by Pejman Nozad and Mar Hershenson, based in Menlo Park, California. The firm specializes in investing in technology companies across various sectors, including consumer, business-to-business, healthcare, biotech, fintech, climate tech, SaaS, and deep tech. Pear targets exceptional founders who are building innovative companies and provides extensive support to help them succeed. The firm has a history of seeding successful startups such as Dropbox and Lending Club, emphasizing its commitment to fostering entrepreneurial talent in North America.

Sand Hill Angels is an angel investor network based in Mountain View, California, founded in 2000. It comprises more than 60 Silicon Valley technology professionals who support startup formation and growth by investing in private technology companies across North America at seed and early stages, including bridge rounds. The group focuses on technology sectors such as clean technology, Internet, information sciences, semiconductors, enterprise software, storage, and communications, as well as life sciences including medical devices, diagnostics, and bioinformatics. Typical investments range from $300,000 to $500,000 with pre-money valuations under about $5 million. The network collaborates with venture capital funds and other angel organizations and actively engages with the Bay Area ecosystem to foster the growth of technology startups.

Verve Ventures is a European venture capital firm and startup investment platform headquartered in Switzerland. It operates a digital platform that connects qualified private investors, family offices and pension funds with startup opportunities, enabling access to private markets and portfolio diversification. Founded in 2010, the firm screens thousands of startups annually and backs a small subset after rigorous due diligence. A pan-European team supports portfolio companies and investor members with networking, hiring and strategic introductions, with offices in Zurich, Lausanne, Berlin, Paris and Cambridge. Verve Ventures focuses on science and technology, climate and energy, robotics and automation, data analytics, advanced manufacturing, clean energy infrastructure and digital health, investing from seed to growth stages across Europe. The platform and network together have funded hundreds of startups, and the firm continues to expand its ecosystem of private and institutional investors and entrepreneurs.

Founded in 1995, Bayern Kapital is a venture capital firm based in Landshut, Germany. It specializes in growth capital investments, focusing on high-tech companies in sectors such as biotechnology, IT, and environmental technology. The firm primarily invests in small and medium-sized companies located exclusively in Bavaria, with typical investment amounts ranging from €0.25 million to €9 million.

Northstar Ventures is a venture capital firm based in Newcastle upon Tyne, United Kingdom. It provides direct investments in early-stage and growth companies and also participates in fund of funds, including private equity funds, accelerators, and incubators. The firm targets sectors such as digital media, entertainment technology, music services, data, telecommunications, clean technology, healthcare and biotechnology, energy, climate tech, computer games, and related technologies. It focuses its activity in the North East region of England, especially County Durham, Northumberland, and Tyne and Wear, and supports portfolio companies with strategic value through its network of university partners, funders, and experienced non-executive directors. Typical investments range from small seed or pre-seed rounds to larger growth rounds, with co-investment alongside other investors. Northstar Ventures emphasizes helping innovative companies create talent, jobs, and growth in the region, contributing to the local innovation ecosystem.

Founded in 2000, Lux Capital is a venture capital firm based in New York and Silicon Valley. It manages over $5 billion in assets, focusing on seed to growth investments at the intersection of technology and sciences. Lux actively supports entrepreneurs building successful businesses in high-growth sectors such as biochemistry, material science, electronics, infrastructure, aerospace, genomics, synthetic biology, and robotics.